• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.儿童慢性炎症性肠病中肿瘤坏死因子α的血清浓度
Gut. 1991 Aug;32(8):913-7. doi: 10.1136/gut.32.8.913.
2
Tumor necrosis factor-alpha is not elevated in children with inflammatory bowel disease.肿瘤坏死因子-α在炎症性肠病患儿中并未升高。
J Pediatr Gastroenterol Nutr. 1991 Feb;12(2):233-6. doi: 10.1097/00005176-199102000-00016.
3
Circulating and mucosal concentrations of tumour necrosis factor and inhibitor(s) in chronic inflammatory bowel disease.慢性炎症性肠病中肿瘤坏死因子及其抑制剂的循环和黏膜浓度
Dan Med Bull. 1993 Apr;40(2):247-9.
4
Longitudinal growth in children and adolescents with inflammatory bowel disease.炎症性肠病患儿及青少年的纵向生长
J Pediatr Gastroenterol Nutr. 1994 Feb;18(2):165-73. doi: 10.1097/00005176-199402000-00008.
5
Growth of prepubertal children with inflammatory bowel disease.患有炎症性肠病的青春期前儿童的生长情况。
J Pediatr Gastroenterol Nutr. 1998 Mar;26(3):310-4. doi: 10.1097/00005176-199803000-00013.
6
Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.克罗恩病和溃疡性结肠炎患者体内的炎症介质与急性期蛋白
Hepatogastroenterology. 1997 Jan-Feb;44(13):90-107.
7
Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.炎症性肠病中外周血单核细胞细胞因子的产生及急性期反应
Gut. 1992 Jun;33(6):773-8. doi: 10.1136/gut.33.6.773.
8
Serum tumor necrosis factor activity in inflammatory bowel disease.炎症性肠病中的血清肿瘤坏死因子活性
Immunopharmacol Immunotoxicol. 1992;14(3):451-61. doi: 10.3109/08923979209005404.
9
C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.C反应蛋白:炎症性肠病中炎症的预测因子和标志物。一项基于人群的前瞻性研究结果
Gut. 2008 Nov;57(11):1518-23. doi: 10.1136/gut.2007.146357. Epub 2008 Jun 19.
10
Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.英夫利昔单抗和其他抗肿瘤坏死因子 α 治疗药物治疗炎症性肠病。
BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000.

引用本文的文献

1
Toward Precision Medicine: Molecular Biomarkers of Response to Tofacitinib in Inflammatory Bowel Disease.迈向精准医学:炎症性肠病中对托法替布反应的分子生物标志物
Genes (Basel). 2025 Jul 29;16(8):908. doi: 10.3390/genes16080908.
2
subsp. 2038 and 1131 ameliorate barrier dysfunction in human induced pluripotent stem cell-derived crypt-villus structural small intestine.亚种2038和1131改善了人诱导多能干细胞衍生的隐窝-绒毛结构小肠中的屏障功能障碍。
Front Immunol. 2025 Jun 11;16:1585007. doi: 10.3389/fimmu.2025.1585007. eCollection 2025.
3
Prediction of deep remission through serum TNF-α level at 1 year of treatment in pediatric Crohn's disease.通过儿童克罗恩病治疗1年时的血清肿瘤坏死因子-α水平预测深度缓解
Sci Rep. 2025 Apr 1;15(1):5770. doi: 10.1038/s41598-025-89578-w.
4
Colitis-induced upregulation of tumor necrosis factor receptor-2 (TNFR2) terminates epithelial regenerative signaling to restore homeostasis.结肠炎诱导的肿瘤坏死因子受体2(TNFR2)上调终止上皮再生信号以恢复体内平衡。
iScience. 2023 Sep 4;26(10):107829. doi: 10.1016/j.isci.2023.107829. eCollection 2023 Oct 20.
5
Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.较高的内脏腹部脂肪组织质量与生物治疗起始时炎症性肠病患者的临床和内镜缓解率较低相关:星座研究的结果。
Gastroenterology. 2023 Oct;165(4):963-975.e5. doi: 10.1053/j.gastro.2023.06.036. Epub 2023 Jul 25.
6
The potential mechanism of huazhuojiedu decoction in the treatment of ulcerative colitis based on network pharmacology and experimental validation.基于网络药理学和实验验证的化浊解毒方治疗溃疡性结肠炎的潜在机制
Front Pharmacol. 2022 Oct 14;13:1033874. doi: 10.3389/fphar.2022.1033874. eCollection 2022.
7
The Autophagy Protein Pacer Positively Regulates the Therapeutic Potential of Mesenchymal Stem Cells in a Mouse Model of DSS-Induced Colitis.自噬蛋白 Pacer 正向调控间充质干细胞在 DSS 诱导的结肠炎小鼠模型中的治疗潜力。
Cells. 2022 Apr 30;11(9):1503. doi: 10.3390/cells11091503.
8
Interleukin 1β Blockade Reduces Intestinal Inflammation in a Murine Model of Tumor Necrosis Factor-Independent Ulcerative Colitis.白细胞介素 1β 阻断减轻肿瘤坏死因子非依赖性溃疡性结肠炎小鼠模型中的肠道炎症。
Cell Mol Gastroenterol Hepatol. 2022;14(1):151-171. doi: 10.1016/j.jcmgh.2022.03.003. Epub 2022 Mar 18.
9
Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment-A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model.英夫利昔单抗的疗效可能与外周隔室中肿瘤坏死因子-α(TNF-α)的完全阻断有关——一种双中心-外周靶点介导的药物处置(TMDD)模型
Pharmaceutics. 2021 Nov 1;13(11):1821. doi: 10.3390/pharmaceutics13111821.
10
Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model.英夫利昔单抗治疗不会导致 TNF-α 完全抑制:一种基于靶点的药物处置模型。
Clin Pharmacokinet. 2022 Jan;61(1):143-154. doi: 10.1007/s40262-021-01057-3. Epub 2021 Aug 5.

本文引用的文献

1
Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease.患有克罗恩病的生长发育迟缓儿童的夜间生长激素和促性腺激素分泌情况
Gut. 1981 Nov;22(11):933-8. doi: 10.1136/gut.22.11.933.
2
Reversal of growth retardation in Crohn's disease with therapy emphasizing oral nutritional restitution.通过强调口服营养恢复的疗法逆转克罗恩病中的生长发育迟缓。
Gastroenterology. 1981 Jan;80(1):10-5.
3
Endocrine dysfunction in children with Crohn's disease.克罗恩病患儿的内分泌功能障碍
J Pediatr Gastroenterol Nutr. 1984 Sep;3(4):529-34. doi: 10.1097/00005176-198409000-00009.
4
Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis.人肠固有层中HLA - DR阳性组织细胞的异质性:组织化学与免疫组织学联合分析
J Clin Pathol. 1983 Apr;36(4):379-84. doi: 10.1136/jcp.36.4.379.
5
Studies on growth hormone secretion in protein-calorie malnutrition.蛋白质-热量营养不良时生长激素分泌的研究。
Am J Clin Nutr. 1968 May;21(5):482-7. doi: 10.1093/ajcn/21.5.482.
6
Nyctohemeral growth hormone levels in children with growth retardation and inflammatory bowel disease.生长发育迟缓与炎症性肠病患儿的昼夜生长激素水平
Gut. 1973 Mar;14(3):191-5. doi: 10.1136/gut.14.3.191.
7
Severe growth retardation in children with inflammatory bowel disease.炎症性肠病患儿的严重生长发育迟缓
Pediatrics. 1970 Mar;45(3):386-93.
8
Delayed gastric emptying in children with Crohn's disease.克罗恩病患儿的胃排空延迟
J Clin Gastroenterol. 1985 Jun;7(3):216-26. doi: 10.1097/00004836-198506000-00007.
9
Linear growth following surgery in children and adolescents with Crohn's disease: relationship to pubertal status.克罗恩病儿童及青少年手术后的线性生长:与青春期状态的关系
J Pediatr Surg. 1985 Apr;20(2):129-33. doi: 10.1016/s0022-3468(85)80284-0.
10
A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia.一种巨噬细胞因子抑制脂肪细胞基因表达:恶病质的体外模型。
Science. 1985 Aug 30;229(4716):867-9. doi: 10.1126/science.3839597.

儿童慢性炎症性肠病中肿瘤坏死因子α的血清浓度

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

作者信息

Murch S H, Lamkin V A, Savage M O, Walker-Smith J A, MacDonald T T

机构信息

Department of Paediatric Gastroenterology, St Bartholomew's Hospital, West Smithfield, London.

出版信息

Gut. 1991 Aug;32(8):913-7. doi: 10.1136/gut.32.8.913.

DOI:10.1136/gut.32.8.913
PMID:1885073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1378961/
Abstract

Serum tumour necrosis factor alpha (TNF alpha) concentrations were measured by enzyme linked immunoadsorbent assay in 31 normal children and during 65 episodes of clinical remission and 54 episodes of relapse in 92 children with chronic inflammatory bowel disease. An appreciable rise in TNF alpha was found only in children in relapse of ulcerative colitis and colonic Crohn's disease. The group of children with small bowel Crohn's disease in relapse did not show increases of TNF alpha above control concentrations, despite an equivalent rise in disease indices. Height velocity was depressed in children with relapse of large bowel Crohn's disease and ulcerative colitis compared with the equivalent condition in remission. The impairment of growth velocity was significantly greater in relapse of large bowel Crohn's disease and ulcerative colitis than in small bowel Crohn's disease alone, although for the subgroups in stage 1 puberty (prepubertal) the differences were not significant. Inadequate growth in chronic inflammatory bowel disease is currently ascribed to inadequate nutrition and TNF alpha may contribute to this through its cachexia inducing effects. It may, in addition, diminish pituitary growth hormone release. These results suggest that production of TNF alpha may be associated with growth failure in relapse of colonic inflammatory bowel disease.

摘要

采用酶联免疫吸附测定法,对31名正常儿童以及92名患有慢性炎症性肠病的儿童在65次临床缓解期和54次复发期的血清肿瘤坏死因子α(TNFα)浓度进行了测量。仅在溃疡性结肠炎和结肠克罗恩病复发的儿童中发现TNFα有明显升高。小肠克罗恩病复发组的儿童,尽管疾病指标有同等程度的升高,但TNFα浓度并未高于对照浓度。与处于缓解期的同等情况相比,大肠克罗恩病和溃疡性结肠炎复发的儿童身高增长速度下降。大肠克罗恩病和溃疡性结肠炎复发时生长速度的受损程度明显大于仅小肠克罗恩病,不过对于1期青春期(青春期前)的亚组而言,差异并不显著。目前认为慢性炎症性肠病患儿生长不足与营养不足有关,而TNFα可能因其诱导恶病质的作用对此有影响。此外,它可能会减少垂体生长激素的释放。这些结果表明,TNFα的产生可能与结肠炎症性肠病复发时的生长衰竭有关。